Navigation Links
PCMA: Independent Drugstore Lobby Continues 'Disclosure Double Standard' Transparency Campaign
Date:12/7/2010

WASHINGTON, Dec. 7, 2010 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) issued the following statement on today's U.S. Department of Labor (DOL) hearing:

"The independent drugstore lobby continues its 'disclosure double standard' campaign of opposing pricing transparency for themselves in Medicaid while demanding more transparency for pharmacy benefit managers (PBMs). This campaign puts its Congressional and retail pharmacy allies in the embarrassing role of attacking and defending the same policy, depending on whether it applies to them or other members of the pharmacy supply chain.

"While the federal 'transparency' provision in the health care law already applies to PBMs -- but not independent retailers -- an interesting irony remains: independent drugstores are themselves the least 'transparent' part of today's pharmacy supply chain.

"Unlike independent drugstores, PBMs are hired by payers to drive down prescription costs, not maximize reimbursements. The Federal Trade Commission (FTC), Government Accountability Office (GAO), Congressional Budget Office (CBO), the Office of Inspector General (OIG), and the Centers for Medicare & Medicaid Services (CMS) have all recognized proven PBM tools generate savings for public and private payers.

"PBMs support policies that empower payers to make informed health care purchasing decisions. However, so-called 'transparency' proposals that would give drugstores and drugmakers access to competitive information would undermine these efforts and only increase prices. The FTC has explored this issue and concluded that the PBM market is extremely competitive and that this kind of 'transparency' would increase, not decrease, costs for consumers."

PCMA represents the nation's pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 200-plus million Americans.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Independent Clinical Results Demonstrate Outstanding Effectiveness of INVOcell Process
2. NCPA Announces Partnership with Live Oak Bank to Help Finance Independent Community Pharmacy Purchases
3. NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges
4. Mid*Lands IRB, LLC - First Independent IRB in Kansas and the Kansas City Area Awarded Accreditation for Protecting Research Participants
5. Independent Community Pharmacies Earn High Customer Satisfaction Scores in Latest J.D. Power and Associates National Pharmacy Study
6. Independent Study Concludes Medicare Competitive Bidding Program for Durable Medical Equipment Could Negatively Affect Care Access, Quality, and Choice for Seniors and People with Disabilities
7. Phase 3 Trial of Aflibercept in Second-Line Metastatic Colorectal Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee
8. NCPA Launches www.PharmacyMatching.com to Connect Independent Pharmacy Buyers and Sellers
9. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
10. K-V Pharmaceutical Company Announces the Nomination and Appointment of New Independent Member to the Board of Directors
11. Abviva Engages W.T. Uniack & Co. As Independent Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):